News

Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.
Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as ...
Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...
This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.
While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary ...
The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...
As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...
Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...
Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and ...
In a recent development, Antengene Corporation Limited announced a global clinical collaboration with Merck (NYSE:MRK) to evaluate ATG-022 in combination with KEYTRUDA®, which could enhance Merck ...